Skip to content
Unrated Drug recall · FDA · Published September 4, 2013

Pfizer Recalls Aldactone 100mg Tablets Due to Manufacturing Issues

Pfizer recalls specific lots of Aldactone (spironolactone) 100 mg tablets distributed by G.D. Searle due to dissolution profile changes from a manufacturing site change.

🇺🇸 FDA recall #D-014-2014DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Us Pharmaceutical Group235 E 42nd St · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer is recalling specific lots of Aldactone (spironolactone) tablets, USP, 100 mg in 100-count bottles because they were marketed without an approved New Drug Application or Abbreviated New Drug Application. The recall addresses changes to the dissolution profile resulting from a change in the manufacturing site. There is currently no approved application supporting this alternate manufacturing location. Read more at govinfonow.com/recall/46643-pfizer-us-pharmaceutical-group-recalls-aldactone-spironolactone-tablets-usp-100.

Source Summary by GovInfoNow · govinfonow.com/recall/46643-pfizer-us-pharmaceutical-group-recalls-aldactone-spironolactone-tablets-usp-100 · Updated October 13, 2026 · FDA enforcement record: FDA #D-014-2014

Cite this page

“Pfizer Recalls Aldactone 100mg Tablets Due to Manufacturing Issues.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46643-pfizer-us-pharmaceutical-group-recalls-aldactone-spironolactone-tablets-usp-100. Based on FDA recall #D-014-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-014-2014%22&limit=1).

The Food and Drug Administration announced on Sept. 4, 2013, that Pfizer Us Pharmaceutical Group is recalling Aldactone (spironolactone) tablets due to a manufacturing site change affecting the dissolution profile. The agency stated there is currently no approved application supporting the alternate manufacturing site.

How to tell if you have it

  • Brand: Pfizer
  • Product: Aldactone Tablets 100 mg
  • NDC: 0025-1031-31
  • Lot #: V121573
  • Expiration: 05/17

The hazard

The recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

Context

GovInfoNow's records show Pfizer Us Pharmaceutical Group has 3 other recalls on record since 2014-02-26. Other recent recalls of similar products include Pfistiq 50mg Recall (2014-04-16), Pfizer Recalls Effexor XR 150 mg Due to Foreign Tikosyn Capsule (2014-03-06), and Advil PM Caplets Recall (2014-02-26). Other recent recalls of similar products include Shoolin Pharma Chem Tadalafil Recall (2026-08-03), Xyvona (Levorphanol) 2mg Tablet Recall (2026-05-22), and SUN PHARMACEUTICAL Xyvona 3mg Tablets Recall (2026-05-22).

How to tell if you have this one

Check if you have Aldactone (spironolactone) tablets, USP, 100 mg in 100-count bottles. Look for NDC 0025-1031-31 and Lot # V121573 with an expiration date of 05/17. The product was distributed nationwide by G.D. Searle, Division of Pfizer Inc.

  • Brand
    Pfizer
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if you have Aldactone tablets with NDC 0025-1031-31 and Lot # V121573 expiring 05/17.

  2. Contact your pharmacist

    Speak with your healthcare provider or pharmacist regarding the recall and appropriate next steps for your prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.6 years after the firm started it.

1. Firm started the recall: Sep 4, 201312. FDA classified it Class II: Nov 20, 201323. Published in FDA’s Enforcement Report: Nov 27, 201334. FDA terminated the recall: Apr 13, 2017420132017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-014-2014 (September 4, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-014-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA